Current Approach of Functioning Head and Neck Paragangliomas: Case Report of a Young Patient with Multiple Asynchronous Tumors.
Alejandro Terrones-LozanoAlan Hernández-HernándezEdgar Nathal VeraGerardo Yoshiaki Guinto-NishimuraJorge Luis Balderrama-BañaresClaudia Ramírez-RenteriaJudith de la Serna-SotoAlfredo Adolfo Reza-AlbarranLesly A Portocarrero-OrtizPublished in: Case reports in endocrinology (2020)
Introduction. Pheochromocytomas (Pheo) and paragangliomas (PGL) are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla and from the extra-adrenal autonomic paraganglia, respectively. Only 1-3% of head and neck PGL (HNPGL) show elevated catecholamines, and at least 30% of Pheo and PGL (PCPG) are associated with genetic syndromes caused by germline mutations in tumor suppressor genes and proto-oncogenes. Clinical Case. A 33-year-old man with a past medical history of resection of an abdominal PGL at the age of eleven underwent a CT scan after a mild traumatic brain injury revealing an incidental brain tumor. The diagnosis of a functioning PGL was made, and further testing was undertaken with a PET-CT with 68Ga-DOTATATE, SPECT-CT 131-MIBG, and genetic testing. Discussion and Conclusion. The usual clinical presentation of functioning PCPG includes paroxistic hypertension, headache, and diaphoresis, sometimes with a suggestive family history in 30-40% of cases. Only 20% of PGL are located in head and neck, of which only 1-3% will show elevated catecholamines. Metastatic disease is present in up to 50% of cases, usually associated with a hereditary germline mutation. However, different phenotypes can be observed depending on such germline mutations. Genetic testing is important in patients with PCPG since 31% will present a germline mutation. In this particular patient, an SDHB gene mutation was revealed, which can drastically influence the follow-up plan and the genetic counsel offered. A multidisciplinary approach is mandatory for every patient presenting with PCPG.SDHB gene mutation was revealed, which can drastically influence the follow-up plan and the genetic counsel offered. A multidisciplinary approach is mandatory for every patient presenting with PCPG.
Keyphrases
- case report
- pet ct
- genome wide
- neuroendocrine tumors
- computed tomography
- positron emission tomography
- dna repair
- squamous cell carcinoma
- small cell lung cancer
- healthcare
- mild traumatic brain injury
- blood pressure
- gene expression
- copy number
- magnetic resonance
- single cell
- heart rate
- magnetic resonance imaging
- dna damage
- quality improvement
- endoplasmic reticulum stress
- genome wide identification